LISATA THERAPEUTICS, INC. (LSTA) Total liabilities 2010–2024
LISATA THERAPEUTICS, INC. (LSTA) total liabilities at each fiscal year-end, per SEC filings.
$3.1MFY2024 · since FY2010: $93.3M → $3.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $3.1M | -44.7% |
| FY2023 | $5.7M | -16.4% |
| FY2022 | $6.8M | +1.3% |
| FY2021 | $6.7M | — |
| FY2015 | $30.0M | -11.4% |
| FY2014 | $33.9M | -50.3% |
| FY2013 | $68.2M | +145.4% |
| FY2012 | $27.8M | +30.9% |
| FY2011 | $21.2M | -77.2% |
| FY2010 | $93.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice